Effect of repeated episodes of reversible myocardial ischemia on myocardial blood flow and function in humans

2002 ◽  
Vol 282 (5) ◽  
pp. H1603-H1608 ◽  
Author(s):  
Edward Barnes ◽  
David P. Dutka ◽  
Masood Khan ◽  
Paolo G. Camici ◽  
Roger J. Hall

Nine patients with coronary artery disease and normal left ventricular (LV) function underwent two episodes of dobutamine-induced ischemia to determine whether repeated episodes of ischemia lead to cumulative stunning. Positron emission tomography (PET) and oxygen 15-labeled H2O was used to assess myocardial blood flow (MBF) at baseline, peak stress, and after stress for each ischemic episode. Quantitative echocardiographic assessment of global ejection fraction (EF) and regional systolic function (SF) was performed at rest and regular intervals after dobutamine. SF was assessed for regions subtended by a coronary artery with a >70% diameter stenosis. Both EF and SF were more severely impaired 45 min after the second episode of stress compared with 45 min after the first (both P < 0.01), despite no difference in duration of the two dobutamine infusions or MBF at peak stress (1.72 vs. 1.69). After both episodes of ischemia, when LV function was impaired but subsequently recovered, MBF (1.15 ± 0.39 and 1.20 ± 0.43, respectively) was no different to baseline MBF (1.02 ± 0.35), confirming that repeated episodes of dobutamine-induced ischemia lead to cumulative myocardial stunning.

Circulation ◽  
1982 ◽  
Vol 66 (3) ◽  
pp. 537-547 ◽  
Author(s):  
P H Chen ◽  
A B Nichols ◽  
M B Weiss ◽  
R R Sciacca ◽  
P D Walter ◽  
...  

Author(s):  
Gian Paolo Rossi ◽  
Teresa Maria Seccia ◽  
Achille Cesare Pessina

AbstractExperimental and observational studies support a role of plasma homocysteine levels (tHcy) in coronary artery disease (CAD). In the GENICA (Genetic and Environmental factors In Coronary Atherosclerosis) study, we found that high tHcy predicted cardiovascular mortality in hypertensive, but not in normotensive, patients independently of CAD and history of myocardial infarction. Moreover, despite not being associated with the coronary atherosclerotic burden, tHcy was inversely associated with left ventricular (LV) ejection fraction. This inverse relationship between LV systolic function and tHcy, which has been independently confirmed, might explain the association of tHcy with the risk of incident heart failure documented in the Framingham Heart Study. Thus, additional mechanistic investigation taking into consideration the effects of tHcy on LV function is necessary to further explore the potential therapeutic usefulness of tHcy lowering treatment in CAD.Clin Chem Lab Med 2007;45:1645–51.


Sign in / Sign up

Export Citation Format

Share Document